A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

PaperCitations, authors & open-access status

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 133 citations, 2019 year and closed oa status.